Evidence map›Paper›PMID 42649509›Full record

ReviewJournal of nanobiotechnology2026

Advanced integrated SERS-based strategies for the early diagnosis of upper gastrointestinal cancers.

Qian Wang, Siyi Jiang, Shuyu Zhai, Wenjia Yin, Yao Sun, Huifang Zhao, Ruiping Zhang

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qian Wang *Academy of Medical Sciences, Shanxi Provincial People's Hospital, Fifth Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, 030001, China.
Siyi Jiang *The First Clinical Medical College of Shanxi Medical University, Taiyuan, 030001, China.
Shuyu ZhaiAcademy of Medical Sciences, Shanxi Provincial People's Hospital, Fifth Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, 030001, China.
Wenjia YinAcademy of Medical Sciences, Shanxi Provincial People's Hospital, Fifth Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, 030001, China.
Yao SunCollege of Biomedicine and Health, Huazhong Agricultural University, Wuhan, 430070, China. sunyaogbasp@ccnu.edu.cn.
Huifang ZhaoTongji Shanxi Hospital, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Shanxi, 030032, China. zhaohf1108@163.com.
Ruiping ZhangAcademy of Medical Sciences, Shanxi Provincial People's Hospital, Fifth Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, 030001, China. zrp_7142@sxmu.edu.cn.ORCID https://orcid.org/0000-0001-6922-0747

Funding

National Key Research and Development Program of China 2023YFC3402800Shanxi Province Science Foundation for Youths 202303021222146the National Natural Science Foundation of China U24A6012
6 · The paper itself

Abstract

Upper gastrointestinal (UGI) cancers are associated with high incidence and poor prognosis due to their insidious onset, posing a serious threat to human health. Traditional diagnostic approaches, including endoscopic biopsy, imaging modalities, and molecular assays, frequently suffer from tedious procedures and insufficient sensitivity. Therefore, it is imperative to develop novel technologies for the early diagnosis of UGI cancers to reduce diagnostic delay, ensure diagnostic accuracy, and ultimately improve patient survival rates. Owing to its exceptional sensitivity and rich molecular fingerprinting information, surface-enhanced Raman spectroscopy (SERS) has emerged as an invaluable analytical tool for uncovering metabolic molecular alterations, thereby facilitating rapid, sensitive, and early-stage diagnosis of UGI cancers. Herein, this review not only outlines the principles and detection strategies of SERS technology, but also highlights its recent advances in the early diagnosis of UGI cancers, particularly in conjunction with other innovative technologies. Ultimately, the current challenges and future development directions are discussed, providing a valuable perspective to guide future efforts toward early UGI cancer screening.

Indexed as

Early Detection of CancerGastrointestinal NeoplasmsSpectrum Analysis, RamanAnimalsHumansConventional diagnostic methodsEarly-stage cancer screeningLabeled SERS diagnostic strategiesLabel-free SERS approachesUGI cancers

Identifiers

PMID42649509
PMCPMC13508314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.